Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Neoadjuvant Therapy × Breast × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 80 Inflammatory Breast Neoplasms 7 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 5 Neoplasm Metastasis 4 Breast Carcinoma In Situ 4 Triple Negative Breast Neoplasms 3 Neoplasms 3 Locally Advanced Breast Cancer 2 Breast Cancer Patients 2 Pathologic Complete Response 1 Neovascularization, Pathologic 1 Margins of Excision 1 Inflammation 1 Infertility 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Lobular 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anxiety Disorders 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡